Filing Details

Accession Number:
0000899243-22-029023
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-17 17:36:17
Reporting Period:
2022-08-15
Accepted Time:
2022-08-17 17:36:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1847529 Joy Liu C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-08-15 206 $300.26 13,146 No 4 S Direct
Common Stock Disposition 2022-08-15 698 $301.63 12,448 No 4 S Direct
Common Stock Disposition 2022-08-15 100 $302.35 12,348 No 4 S Direct
Common Stock Disposition 2022-08-15 700 $303.99 11,648 No 4 S Direct
Common Stock Disposition 2022-08-15 1,743 $305.01 9,905 No 4 S Direct
Common Stock Disposition 2022-08-15 300 $305.57 9,605 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
  2. Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $300.26 (range $300.00 to $300.28).
  4. Open market sales reported on this line occurred at a weighted average price of $301.63 (range $301.23 to $302.01).
  5. Open market sales reported on this line occurred at a weighted average price of $303.99 (range $303.48 to $304.46).
  6. Open market sales reported on this line occurred at a weighted average price of $305.01 (range $304.54 to $305.53).
  7. Open market sales reported on this line occurred at a weighted average price of $305.57 (range $305.55 to $305.58).